Kairos Pharma (KAPA) Current Assets (2023 - 2025)
Kairos Pharma's (KAPA) quarterly Current Assets came in at $5.4 million in Q4 2025, up 29.22% YoY from $4.2 million in Q4 2024, and up 11.32% on a QoQ basis from $4.8 million in Q2 2025.
Kairos Pharma (KAPA) Current Assets (2023 - 2025) Analysis & Trends
Kairos Pharma (KAPA) has 3 years of Current Assets data on file, last reported at $5.4 million in Q4 2025.
- Quarterly Current Assets rose 29.22% year-over-year to $5.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.4 million (up 29.22% YoY) and the FY2025 annual result came in at $5.4 million, up 29.22% from the prior year.
- Current Assets advanced to $5.4 million in Q4 2025, from $4.8 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $6.0 million in Q1 2025 to a low of $101000.0 in Q4 2023.
- A 3-year average of $4.2 million and a median of $4.8 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets jumped 4027.72% — and 2025, when it increased 29.22%.
- Tracing KAPA's Current Assets over 3 years: stood at $101000.0 in 2023, then jumped by 4027.72% to $4.2 million in 2024, then rose by 29.22% to $5.4 million in 2025.
- The last three Current Assets figures came in at $5.4 million (Q4 2025), $4.8 million (Q2 2025), and $6.0 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Kairos Pharma | 5.50 Mn | 168,380.07 | - | 5.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.39 Mn |
| Jun 30, 2025 | 4.84 Mn |
| Mar 31, 2025 | 6.05 Mn |
| Dec 31, 2024 | 4.17 Mn |
| Sep 30, 2024 | 4.74 Mn |
| Dec 31, 2023 | 101,000.00 |